Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.78 USD | +1.05% | +1.54% | +7.61% |
Apr. 17 | ReNeuron Group Reports CFO Resignation | MT |
Apr. 17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.61% | 1.59B | B- | ||
-0.19% | 74.89B | B | ||
+0.09% | 46.52B | A- | ||
-4.19% | 30.82B | C | ||
+9.85% | 18.19B | B | ||
-10.05% | 11.54B | B | ||
+6.39% | 11.24B | A- | ||
-8.09% | 9.73B | - | ||
+2.79% | 9.4B | A- | ||
+6.35% | 9.37B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HWKN Stock
- Ratings Hawkins, Inc.